For example, in mainly CD4+ T cell-driven autoimmune diseases, a selective immunosuppression of these cells would leave anti-viral and anti-tumor reactive CD8+ T cells intact and therefore circumvent potential side effects of global T cell suppression as currently used. This evidence concerns the gene CD8A and autoimmune disease.